• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非层状液晶形成脂质开发应用于口腔黏膜的喷雾制剂。

Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.

作者信息

Sugibayashi Kenji, Yamamoto Nao, Itakura Shoko, Okada Akie, Hijikuro Ichiro, Todo Hiroaki

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.

Farnex Co., Inc., Tokyo Institute of Technology Yokohama Venture Plaza.

出版信息

Chem Pharm Bull (Tokyo). 2020;68(11):1025-1033. doi: 10.1248/cpb.c20-00333.

DOI:10.1248/cpb.c20-00333
PMID:33132369
Abstract

We examined the physicochemical and biochemical properties of mono-O-(5,9,13-trimethyl-4-tetradecenyl)glycerol ester (MGE), including ease of handling, high bioadhesiveness, quick and stable in vivo self-organization (forming a non-lamellar lyotropic liquid crystal [NLLC]), and high biomembrane permeation enhancement. We prepared MGE oral mucosa-applied spray preparations containing triamcinolone acetonide (TA), which is widely used in the treatment of stomatitis, and we examined the usefulness of the MGE preparations compared with commercially available oral mucosal application preparations containing 2,3-dihydroxypropyl oleate (1-mono(cis-9-octadecenoyl)glycerol (GMO) (previously studied as an NLLC-forming lipid) preparation. As a result, the MGE preparation applied to the oral mucosa can rapidly formed an NLLC with reverse hexagonal or cubic structures, or a mixture, on contact with water. In addition, by adding hydroxypropyl cellulose to the MGE preparation, similar retention properties on the oral mucous membrane were obtained to that using marketed drug preparations. Furthermore, the MGE spray formulation on the oral mucosa showed an equivalent or higher TA release as well as oral mucous membrane permeability compared with commercial formulations. Because MGE forms a stable NLLC and is easy to handle compared with GMO, MGE was considered to be a useful pharmaceutical additive for a spray preparation applied to the oral mucosa in combination.

摘要

我们研究了单 -O-(5,9,13 - 三甲基 -4 - 十四碳烯基)甘油酯(MGE)的物理化学和生化特性,包括易于处理、高生物粘附性、在体内快速且稳定地自我组织(形成非层状溶致液晶 [NLLC])以及高生物膜渗透增强作用。我们制备了含有广泛用于治疗口腔炎的曲安奈德(TA)的MGE口腔黏膜应用喷雾剂制剂,并与含有油酸2,3 - 二羟丙酯(1 - 单(顺式 -9 - 十八碳烯酰基)甘油(GMO)(先前作为形成NLLC的脂质进行研究)的市售口腔黏膜应用制剂相比,研究了MGE制剂的实用性。结果,应用于口腔黏膜的MGE制剂在与水接触时可迅速形成具有反六边形或立方结构或混合物的NLLC。此外,通过向MGE制剂中添加羟丙基纤维素,获得了与市售药物制剂在口腔黏膜上相似的保留特性。此外,与市售制剂相比,口腔黏膜上的MGE喷雾制剂显示出相当或更高的TA释放以及口腔黏膜渗透性。由于MGE与GMO相比形成稳定的NLLC且易于处理,因此MGE被认为是一种用于联合应用于口腔黏膜的喷雾制剂的有用药物添加剂。

相似文献

1
Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.使用非层状液晶形成脂质开发应用于口腔黏膜的喷雾制剂。
Chem Pharm Bull (Tokyo). 2020;68(11):1025-1033. doi: 10.1248/cpb.c20-00333.
2
Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.控制模型亲水性高分子化合物从含有不同类型磷脂的可注射非层状液晶制剂中的释放。
Int J Pharm. 2020 Mar 15;577:118944. doi: 10.1016/j.ijpharm.2019.118944. Epub 2019 Dec 21.
3
Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.亲水性药物透过丙烯酸类压敏胶带的皮肤渗透增强作用。
Pharm Res. 2021 Feb;38(2):289-299. doi: 10.1007/s11095-021-02996-z. Epub 2021 Jan 29.
4
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.一种含有新型非层状液晶形成脂质的基于脂质的储库制剂。
Pharm Res. 2021 Mar;38(3):503-513. doi: 10.1007/s11095-021-03014-y. Epub 2021 Feb 26.
5
A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C-Monoglycerol Ester Liquid Crystal-forming Lipid.一种使用C-单甘油酯液晶形成脂质的新型透皮给药化学增强剂方法。
J Oleo Sci. 2017 May 1;66(5):443-454. doi: 10.5650/jos.ess16204. Epub 2017 Apr 4.
6
Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.口服和局部应用液晶药物制剂的研发与优化
J Oleo Sci. 2017;66(9):939-950. doi: 10.5650/jos.ess17032.
7
Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate.开发自我给药制剂以提高醋酸亮丙瑞林的生物利用度。
Pharmaceutics. 2022 Apr 3;14(4):785. doi: 10.3390/pharmaceutics14040785.
8
Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.口服和透皮给药系统:基于脂质的溶致液晶的作用
Drug Des Devel Ther. 2017 Feb 13;11:393-406. doi: 10.2147/DDDT.S103505. eCollection 2017.
9
Characterization of a Liquid Crystal System for Sustained Release of a Peptide BMS-686117.用于肽 BMS-686117 持续释放的液晶系统的表征。
AAPS PharmSciTech. 2018 Jan;19(1):348-357. doi: 10.1208/s12249-017-0835-9. Epub 2017 Jul 24.
10
Enhanced permeation of triamcinolone acetonide through the buccal mucosa.曲安奈德经颊黏膜的渗透增强。
Eur J Pharm Biopharm. 2000 Sep;50(2):217-20. doi: 10.1016/s0939-6411(00)00101-6.

引用本文的文献

1
Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.液晶纳米颗粒作为药物递送系统的研究进展
Pharmaceutics. 2023 May 6;15(5):1421. doi: 10.3390/pharmaceutics15051421.
2
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.一种含有新型非层状液晶形成脂质的基于脂质的储库制剂。
Pharm Res. 2021 Mar;38(3):503-513. doi: 10.1007/s11095-021-03014-y. Epub 2021 Feb 26.